Meeting with Mr.Alok Kumar IAS ,Prl.Secy Medical (UP) on 25rh April 2025.at BDMA Office, Sanathnagar
MoU with TGCHE on 8th February 2025
SME InFocus Meet on 24th Jan 2025
Industry Interaction with USP India Team on 9th Jan 2025
India UAE and Australia Trade Agreements 23.April.2022
Workshop on Analytical Method Development Nitrosamine Impurities & Process Safety 2nd Feb 2024
Meeting with USP at-BDMA T&T Centre on 2nd Feb 2024
Meeting with USFDA India Team on 26th Feb 2024
Updates
Availability of QC Manpower trained in BDMA T & T Center
Sectoral Plan for Effective Logistics – Pharma Sector
BDMAI News Letter – Material contribution by Members
Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.
Pharma MSME Industry Meet – 24.1.2025
Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB
MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education
Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025
Allotment of land in Green Pharma City, Telangana
New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs
Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies
ICH Guidelines- Q7- Telugu Translated version
Special offer by Avila International – Travel Package – CPhI China
Online Application for implementation of Schedule M
Nomination for Internal Committees of BDMAI
Availability of QC Manpower trained in BDMA T & T Center
Sectoral Plan for Effective Logistics – Pharma Sector
BDMAI News Letter – Material contribution by Members
Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.
Pharma MSME Industry Meet – 24.1.2025
Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB
MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education
Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025
Allotment of land in Green Pharma City, Telangana
New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs
Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies
ICH Guidelines- Q7- Telugu Translated version
Special offer by Avila International – Travel Package – CPhI China
Meeting with Mr.Alok Kumar IAS ,Prl.Secy Medical (UP) on 25rh April 2025.at BDMA Office, Sanathnagar
MoU with TGCHE on 8th February 2025
SME InFocus Meet on 24th Jan 2025
Felicitation to Sri GV Prasad on 18th September 2025
Office Bearers of BDMA
Workshop on Analytical Method Development Nitrosamine Impurities & Process Safety 2nd Feb 2024
Meeting with USP at-BDMA T&T Centre on 2nd Feb 2024
Meeting with USFDA India Team on 26th Feb 2024
Your Caption for Slide 9 - Add your image URL and caption here
Your Caption for Slide 10 - Add your image URL and caption here
Your Caption for Slide 11 - Add your image URL and caption here
Your Caption for Slide 12 - Add your image URL and caption here
Your Caption for Slide 13 - Add your image URL and caption here
Your Caption for Slide 14 - Add your image URL and caption here
Your Caption for Slide 15 - Add your image URL and caption here
Your Caption for Slide 16 - Add your image URL and caption here
Updates
Welcome to BDMAI
The Bulk Drug Manufacturers Association (India) was formed in 1991 with Hyderabad as its Head Quarters. This is an all India body representing most of the Bulk Drug Manufacturers of India. The Association works for the consolidation of gains of the industry and serves as a coordinator and catalyst between the government and the industry for the growth of the industry.
About Us
BDMA T&T Centre
UNIFORM CODE OF PHARMACEUTICAL MARKETING PRACTICES
ATTENTION MEMBERS
The Department of Pharmaceuticals has forwarded the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) informing that it is being implemented to all pharmaceutical manufacturers (COPY AVAILABLE IN PORTALS OF BDMA WEBSITE)
Members will be aware that DoP has published a voluntary Code of Marketing Practices quite some time ago for Pharmaceutical companies and is committed to the code of ethical marketing practices broadly in line with the UCPMP. BDMA Association may be seized of the matter and will be discussing the same with the Government and other authorities so that the industry as a whole adheres to a workable practical Code.
Though the Code is voluntary, Members are requested to adhere to the same to ensure ethical and transparent marketing practices.
Encl: UCPMP GUIDELINES ARE AVAILABLE IN PORTALS CATEGORY OF BDMA WEBSITE
Thanks and regards,
~CH AP Rameswara Rao
National President
Resource Centre
Top 50 importing companies
Read More…
Regulatory Agency
Read More…
New Drug Theraphy Approvals
Read More…
From the Desk of President
~BDMAI
It is gratifying to note that I had been elected as National President along with other senior leaders who were elected as Office Bearers and Executive Committee Members in the Annual General Body Meeting held on 18th of September 2025. This kind gesture by all of you reminds me to be humble and discharge my duties with full responsibility.
~ ch ap rameswara rao
National President
